Evaluation of the efficacy and safety of switching to tenofovir, emtricitabine, and rilpivirine in treatment-experienced patients.
暂无分享,去创建一个
A. Boyd | P. Girard | C. Viala | J. Meynard | L. Morand‐Joubert | N. Valin | L. Fonquernie | L. Surgers
暂无分享,去创建一个
A. Boyd | P. Girard | C. Viala | J. Meynard | L. Morand‐Joubert | N. Valin | L. Fonquernie | L. Surgers